PICO Portalanswers from OpenAlex & ORCID
Masashi Mizuno
ResearcherPublications, citations & collaboration network
Masashi Mizuno is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Masashi Mizuno have?
PICO Portalindexed works
Masashi Mizuno has 301 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Masashi Mizuno have?
PICO Portalcitation count
Masashi Mizuno has 5,941 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Masashi Mizuno?
PICO Portalh-index
Masashi Mizuno has an h-index of 43 in OpenAlex.
What is the i10-index of Masashi Mizuno?
PICO Portali10-index
Masashi Mizuno has an i10-index of 132 in OpenAlex.
What is the ORCID of Masashi Mizuno?
PICO Portalorcid
The ORCID for Masashi Mizuno is on the source record.
What is the OpenAlex record for Masashi Mizuno?
PICO Portalopenalex
The OpenAlex for Masashi Mizuno is on the source record.
What are the most-cited papers on Masashi Mizuno?
PICO Portalmost cited works
Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis
Jonathan Fallowfield, Masashi Mizuno, Timothy J. Kendall, Christothea M. Constandinou, R. Christopher Benyon, Jeremy S. Duffield, John P. Iredale
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts
Masashi Mizuno, Atsushi Kuno, Toshiyuki Yano, Takayuki Miki, H Oshima, Tatsuya Sato, Kei Nakata, Yukishige Kimura, Masaya Tanno, Tetsuji Miura
CD46 Plays a Key Role in Tailoring Innate Immune Recognition of Apoptotic and Necrotic Cells
Kristina Elward, Mark Griffiths, Masashi Mizuno, Claire L. Harris, J. W. Neal, B. Paul Morgan, Philippe Gasque
Hip Fracture Prevention Trial Using Hip Protectors in Japanese Nursing Homes
Atsushi Harada, Masashi Mizuno, Marie Takemura, Haruhiko Tokuda, Hiroyasu Okuizumi, Naoakira Niino
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
H Oshima, Takayuki Miki, Atsushi Kuno, Masashi Mizuno, Tatsuya Sato, Masaya Tanno, Toshiyuki Yano, Kei Nakata, Yukishige Kimura, Koki Abe, Wataru Ohwada, Tetsuji Miura